Janet Newman

Dr. Janet Newman

orcid

Research Focus & Metrics

Academic Career Length

37Years (1990-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 August 2020 in The EMBO Journal
Verified
Journal Article
Open access
PDF file
TKTheresa Klemm
Theresa Klemm
GEGregor Ebert
Gregor Ebert
DCDale J Calleja
Dale J Calleja
CACody C Allison
Cody C Allison
LRLachlan W Richardson
Lachlan W Richardson
DKDavid Komander
David Komander
EMBO Press is an editorially independent publishing platform for the development of EMBO scientific publications.

28 September 2005 in Acta Crystallographica Section D Structural Biology
Verified
Journal Article
Open access
PDF file
JNJanet Newman
Janet Newman
DEDavid Egan
David Egan
TWThomas S. Walter
Thomas S. Walter
RMRan Meged
Ran Meged
IBIan Berry
Ian Berry
APAnastassis Perrakis
Anastassis Perrakis
A crystallization screening process is presented that was developed for a small academic laboratory. Its underlying concept is to combine sparse-matrix screening with systematic screening in a minimum number of crystallization conditions. The sparse-matrix screen is the cherry-picked combination of conditions from the Joint Center for Structural Genomics (JCSG) extended using conditions from other screens. Its aim is to maximize the coverage of crystallization parameter space with no redundancy. The systematic screen, a pH-, anion- and cation-testing (PACT) screen, aims to decouple the components of each condition and to provide information about the protein, even in the absence of crystals, rather than cover a wide crystallization space. This screening strategy is combined with nanolitre-volume dispensing hardware and a small but practical experiment-tracking system. The screens have been tested both at the NKI and in other laboratories and it is concluded that they provide a useful minimal screening strategy.

14 July 2005 in Proteins: Structure, Function, and Bioinformatics
Verified
Journal Article
Closed access
PDF file
JBJ. Badger
J. Badger
JSJ.M. Sauder
J.M. Sauder
JAJ.M. Adams
J.M. Adams
SAS. Antonysamy
S. Antonysamy
KBK. Bain
K. Bain
THT.J.R. Harris
T.J.R. Harris

27 August 2010 in Molecular Microbiology
Verified
Journal Article
Open access
PDF file
MTMatthew Taylor
Matthew Taylor
CJColin J. Jackson
Colin J. Jackson
DTDavid B. Tattersall
David B. Tattersall
NFNigel French
Nigel French
TPThomas Peat
Thomas Peat
JOJohn G. Oakeshott
John G. Oakeshott
Summary: Aflatoxins are polyaromatic mycotoxins that contaminate a range of food crops as a result of fungal growth and contribute to serious health problems in the developing world because of their toxicity and mutagenicity. Although relatively resistant to biotic degradation, aflatoxins can be metabolized by certain species of Actinomycetales. However, the enzymatic basis for their breakdown has not been reported until now. We have identified nine Mycobacterium smegmatis enzymes that utilize the deazaflavin cofactor F420H2 to catalyse the reduction of the α,β‐unsaturated ester moiety of aflatoxins, activating the molecules for spontaneous hydrolysis and detoxification. These enzymes belong to two previously uncharacterized F420H2 dependent reductase (FDR‐A and ‐B) families that are distantly related to the flavin mononucleotide (FMN) dependent pyridoxamine 5′‐phosphate oxidases (PNPOxs). We have solved crystal structures of an enzyme from each FDR family and show that they, like the PNPOxs, adopt a split barrel protein fold, although the FDRs also possess an extended and highly charged F420H2 binding groove. A general role for these enzymes in xenobiotic metabolism is discussed, including the observation that the nitro‐reductase Rv3547 from Mycobacterium tuberculosis that is responsible for the activation of bicyclic nitroimidazole prodrugs belongs to the FDR‐A family.

12 November 1999 in Biochemistry
Verified
Journal Article
Closed access
JNJanet Newman
Janet Newman
TPThomas Peat
Thomas Peat
RRRuth Richard
Ruth Richard
LKLynn Kan
Lynn Kan
PSPaul E. Swanson
Paul E. Swanson
TTThomas C. Terwilliger
Thomas C. Terwilliger

21 December 2015 in Nature Communications
Verified
Journal Article
Open access
AWAndrew Warden
Andrew Warden
MWMichelle Williams
Michelle Williams
TPThomas Peat
Thomas Peat
SSShane A. Seabrook
Shane A. Seabrook
JNJanet Newman
Janet Newman
VHVictoria S. Haritos
Victoria S. Haritos
Enzymes expressed by highly salt-tolerant organisms show many modifications compared with salt-affected counterparts including biased amino acid and lower α-helix content, lower solvent accessibility and negative surface charge. Here, we show that halotolerance can be generated in an enzyme solely by modifying surface residues. Rational design of carbonic anhydrase II is undertaken in three stages replacing 18 residues in total, crystal structures confirm changes are confined to surface residues. Catalytic activities and thermal unfolding temperatures of the designed enzymes increase at high salt concentrations demonstrating their shift to halotolerance, whereas the opposite response is found in the wild-type enzyme. Molecular dynamics calculations reveal a key role for sodium ions in increasing halotolerant enzyme stability largely through interactions with the highly ordered first Na+ hydration shell. For the first time, an approach to generate extreme halotolerance, a trait with broad application in industrial biocatalysis, in a wild-type enzyme is demonstrated.